Apr 21, 2026 06:01AM Personalis presents clinical data on cancer monitoring technology at AACR

Mar 12, 2026 06:02AM Personalis publishes breast cancer study in Journal of Clinical Oncology

Mar 4, 2026 05:20PM Personalis (PSNL) PT Lowered to $10 at Morgan Stanley

Feb 27, 2026 06:17AM Personalis (PSNL) PT Raised to $12 at Needham

Feb 27, 2026 06:07AM BTIG Reiterates Buy Rating on Personalis (PSNL)

Feb 26, 2026 04:22PM Personalis, Inc. (PSNL) Tops Q4 EPS by 4c, provides guidance

Feb 10, 2026 06:00AM Personalis gains Medicare coverage for lung cancer test

Feb 2, 2026 06:01AM Personalis study shows ctDNA test detects immunotherapy response early

Dec 17, 2025 06:00AM Personalis study shows blood test predicts cancer patient outcomes

Nov 25, 2025 06:15AM Personalis receives Medicare reimbursement rates for cancer tests

Nov 10, 2025 01:33PM Personalis (PSNL) PT Raised to $12 at BTIG

Nov 5, 2025 06:16AM Personalis (PSNL) PT Raised to $10 at Needham

Nov 4, 2025 04:50PM Personalis, Inc. (PSNL) Tops Q3 EPS by 4c, provides guidance

Sep 8, 2025 07:15AM H.C. Wainwright Reiterates Buy Rating on Personalis (PSNL)

Sep 3, 2025 04:06PM Personalis lung cancer test shows higher sensitivity in clinical trial

Aug 5, 2025 04:06PM Personalis, Inc. (PSNL) Tops Q2 EPS by 1c, provides guidance

Jul 9, 2025 04:00PM Personalis extends Tempus partnership to include colorectal cancer testing

Jun 3, 2025 04:02PM Personalis, Inc. (PSNL) announces presentation of results from CALLA phase 3 study at ASCO 2025

May 7, 2025 07:17AM Personalis (PSNL) PT Raised to $9 at H.C. Wainwright

May 6, 2025 04:05PM Personalis, Inc. (PSNL) Tops Q1 EPS by 7c ; Offers Guidance

Mar 17, 2025 07:10AM Craig-Hallum Starts Personalis (PSNL) at Buy

Mar 3, 2025 01:16PM Personalis (PSNL) PT Lowered to $7 at BTIG

Feb 28, 2025 08:03AM Personalis (PSNL) PT Lowered to $7 at Needham

Feb 27, 2025 04:14PM Personalis, Inc. (PSNL) Tops Q4 EPS by 6c

Jan 27, 2025 07:12AM Personalis (PSNL) PT Lowered to $8 at H.C. Wainwright

Jan 8, 2025 08:41AM Personalis (PSNL) PT Raised to $9 at Lake Street Capital Markets

Dec 20, 2024 06:43AM Personalis (PSNL) PT Raised to $11 at H.C. Wainwright

Dec 19, 2024 09:00AM Personalis, Inc. (PSNL) Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Nov 6, 2024 04:03PM Personalis, Inc. (PSNL) Misses Q3 EPS by 29c, Beats on Revenue

Aug 30, 2024 04:44PM Personalis, Inc. (PSNL) Files for 3.5M Share Offering by Selling Stockholders

Aug 19, 2024 12:06PM Personalis (PSNL) PT Raised to $8 at Lake Street Capital Markets

Aug 19, 2024 07:34AM TD Cowen Reiterates Buy Rating on Personalis (PSNL)

Aug 19, 2024 06:39AM Personalis (PSNL) PT Raised to $9 at H.C. Wainwright

Aug 16, 2024 02:52PM Personalis (PSNL) PT Raised to $7 at BTIG

Aug 16, 2024 08:31AM Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration

Aug 8, 2024 01:25PM Personalis (PSNL) PT Raised to $5.50 at BTIG

Aug 8, 2024 06:28AM Personalis (PSNL) PT Raised to $5.50 at Needham

Jun 21, 2024 01:25PM Needham Reiterates Buy Rating on Personalis (PSNL)